Measurement of the MMP-9:TIMP-1 protein:protein complex concentrations in plasma from breast cancer patients for prognostic purposes has not previously been described although numerous publications have indicated that both molecules, when measured individually, are indicative of patient prognosis [5,6,11,15]. Here, MMP9 is linked to breast carcinoma.